Robert Stanley Sherwin MD
C. N. H. Long Professor of Medicine (Endocrinology); Section Chief, Endocrinology; Associate Dean for Clinical and Translational Sciences; Director, Yale Center for Clinical Investigation; Director, Yale Diabetes Research Center
Robert S. Sherwin. MD is the C.N.H. Professor of Medicine in the Section of Endocrinology at Yale University School of Medicine in New Haven, CT. He graduated from the Albert Einstein College of Medicine in 1967. After his residency in internal medicine at Mount Sinai Hospital (N Y), he served as a research fellow in metabolism and diabetes at the National Institutes of Health. In 1972 Dr Sherwin moved to Yale University School of Medicine where he was a postdoctoral fellow and subsequently was appointed to the faculty in 1974. He currently serves Chief of the Section of Endocrinology as well as the Director of the CTSA-funded Yale Center for Clinical Investigation and the NIDDK-funded Diabetes Research Center at Yale. His special clinical interests include patients with type 1 diabetes, intensified insulin therapy, complicated type 2 diabetes patients, and hypoglycemia associated with diabetes. Dr Sherwin’s research activities span clinical and basic research and are focused on brain glucose sensing mechanisms mediating the activation of counterregulatory responses and the impact of hypoglycemia and insulin on brain function and metabolism as well as the changes in brain function that drive disordered glucose control and eating behavior using brain imaging techniques (fMRI, spectroscopy, and PET) in both diabetes and obesity. Dr. Sherwin has served as President of the American Diabetes Association and as a member of the FDA Advisory Committee for Endocrinologic and Metabolic Drugs. He has served as the Chairman of the Medical Science Advisory Board of the JDRF and on the editorial boards of leading diabetes and endocrine journals. He has published over 400 articles in peer-reviewed journals and is the recipient of numerous scientific awards including the American Diabetes Association’s Banting Award for lifetime scientific achievement, the Novartis Award for long-standing achievement in diabetes, and 2 MERIT Awards from the NIH.